
Agile Therapeutics

Novartis

H. Lundbeck A/S

Bywater Consulting Group

Acorda Therapeutics

Healthcare Businesswomen's Association (HBA)

Amicus Therapeutics

Beyond Spring

MSD, Montes Claros, MG, Brazil

Biotechnology Innovation Organization

Syros Pharmaceuticals

Janssen Supply Chain

Warburg Pincus

Nkarta Therapeutics

GSK

Life Science Leader

Ferring Pharmaceutical, Inc.

Heron Therapeutics

GlycoMimetics

Sanofi

PureTech Health

Merck

Context Therapeutics

Sangamo Therapeutics

Cognition Therapeutics

Sequella

Acceleron Pharma

Candel Therapeutics

Aisling Capital

Bioniz Therapeutics

Bayer

MichBio

BioEclipse Therapeutics

Alexion

Life Science Leader

Transparency Life Sciences

Maverick Therapeutics

Radius Health


Voyager Therapeutics

MedImmune / AstraZeneca

Alexion

Dermira

ImmusanT

MiMedx
ASK THE BOARD
- What Happens If We Have A Bunch Of COVID-19 Therapeutic And Vaccine Development Failures? Could Biopharma Be The Next Dot-Com Bubble To Burst In 2021?
- What COVID-19-Induced Trends Impacting Your Company’s Operations Do You Anticipate Continuing Well Beyond The End Of The Current Pandemic?
- Could The Pandemic Be Just What The Doctor Ordered For Bringing More R&D Minds To Major Biopharma Hubs (e.g., Boston, San Fran)?
- What — If Any — “Silver Linings” Have You Observed Take Place At Your Company Resulting From The Chaos Caused By COVID-19?
- What Was Your Biggest Business Learning From The First Half Of 2020 And Why?
- What Is Your Biggest Concern Regarding Biopharma’s Reputation With The American People If We Do Not Have A COVID-19 Vaccine By The End Of 2020?
IN THIS MONTH'S ISSUE
-
Most Favored Nation Pricing Temporarily Halted By Courts
In late December, the courts halted President Trump’s international reference-pricing scheme, the Most Favored Nation model, saying the administration had improperly attempted to implement a radical change in Medicare reimbursement policy.
-
Going Public In Mid-Pandemic
Just as the COVID pandemic hit, Timber Pharma was planning on going public. But that wasn’t the only challenge the company faced in the months ahead.
-
5 Elements Of A Long-Term Partnership Strategy
Throughout my career, I have seen partnerships that succeed and those that fail. Through this experience, I have been able to identify what it takes to build and maintain partnerships that stand the test of time.
-
Benefits Of Beantown Biotech And Lessons For Life Science Leaders
I have had the opportunity to experience and contribute to the thriving life sciences industry in Massachusetts, and I can say that it has all of the components needed to ultimately bring new treatments forward for patients.
-
Increasing Patient Diversity In Clinical Trials
The COVID-19 pandemic has spotlighted healthcare’s biggest shortfalls. One of the most glaring problems sounds like it should be simple to resolve, but it has actually been challenging to implement — diversity in clinical trials.
BEYOND THE PRINTED PAGE
@LIFESCILEADER1
EVENTS
-
Master Excel: Spreadsheet Internal Controls
January 18, 2021
-
Personal Protective Equipment Requirements
January 18, 2021
-
Directors and Managers in Food Safety and Quality Personnel
January 20, 2021
-
Hazardous Material Release Reporting Requirements
January 25, 2021
-
Dietary Supplements CGMPS - 21 CFR 111 Compliance
February 2, 2021